Peripheral artery disease trials in China

In China 24 Also abroad 233

13 of 24 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Where
Beijing, Chengdu, Guangzhou, Harbin, Luoyang Shi, Nanjing, Shanghai, Tianjin, Wenzhou, Wuhan, Xi'an
Age
18 years and over
People
1,205 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07223593 · EU 2025-523283-21-00
No phaseTaking people
Construction and Empirical Research of a Risk Prediction Model for Preventing Lower Extremity Arteriosclerosis Obliterans in Diabetic Patients Based on the HAPA Model
Where
Nanchang
Age
18 years and over
People
154
Run by
Second Affiliated Hospital of Nanchang University
See details and how to joinNCT07881588
Phase 2/3Taking people
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
Where
Baotou Shi, Beijeing, Beijing, Chengdu, Dalian, Deyang Shi, Dongguan, Foshan Shi, Guangzhou, Hefei, Jiaxing, Lanzhou, Luoyang Shi, Mianyang, Nanchang, Nanjing, Nanning, Pingxiang, Shanghai, Shanghai Shi, Shenzhen, Shijiazhuang, Taiyuan, Tianjin, Wuhan, Wuxi, Xiamen, Xianyang, Xinxiang, Yangzhou, Yibin, Zhengzhou, Zhenjiang
Age
18 years and over
People
3,110 worldwide
Run by
CSL Behring
See details and how to joinNCT05485961 · EU 2022-500273-14-00
Phase 4Not yet taking people in China
Seltoplasmid Plus Revascularization for Diabetic Infrapopliteal Chronic Limb-Threatening Ischemia
Where
Hangzhou, Taizhou, Wenzhou
Age
18 years and over
People
180
Run by
First Affiliated Hospital of Wenzhou Medical University
See details and how to joinNCT07827521
Phase 3Not yet taking people in China
Evaluating Bu Yang Huanwu Decoction For Early Diabetic Vascular Disease
Where
Beijing
Age
18 years to 70 years
People
300
Run by
Xuanwu Hospital, Beijing
See details and how to joinNCT07658807
No phaseTaking people
Stents Post-dilation With DCB or POBA in Femoropopliteal Arteries
Where
Shanghai
Age
18 years to 80 years
People
180
Run by
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
See details and how to joinNCT03791970
Phase 2Taking people
A Study of SRSD107 in Participants With Chronic Coronary and/or Peripheral Arterial Disease
Where
Beijing
Age
18 years to 75 years
People
104
Run by
Sirius Therapeutics Co., Ltd.
See details and how to joinNCT07318155
No phaseTaking people
Safety and Effectiveness of the Peripheral Balloon-Expandable Covered Stent System for Iliac Artery Stenosis/Occlusion. (SELECT)
Where
Beijing
Age
18 years to 80 years
People
130
Run by
Zhejiang Zylox Medical Device Co., Ltd.
See details and how to joinNCT06605209
No phaseTaking people
A Trail of Sperstent® Used for Residual Lesions of Femoropopliteal Arteries
Where
Beijing, Chengdu, Chongqing, Hangzhou, Luzhou, Nanjing, Nantong, Shanghai, Shijiazhuang, Wuhan, Zhengzhou
Age
18 years to 85 years
People
240
Run by
FrontAce Scientific Co., Ltd
See details and how to joinNCT06539689
No phaseTaking people
ACOART BTK RENEW：A Post Market Clinical Study
Where
Beijing
Age
18 years to 75 years
People
107
Run by
Acotec Scientific Co., Ltd
See details and how to joinNCT04885985
No phaseNot yet taking people in China
The Efficacy of Heparin-boned Viabahn Endoprosthesis and Paclitaxel-coated Balloons for Complex Femoropopliteal Lesions
Where
Shanghai
Age
18 years and over
People
60
Run by
RenJi Hospital
See details and how to joinNCT06124755
No phaseTaking people
Smart Flex Stent System for the Treatment Long Femoropopliteal Artery Lesions
Where
Shanghai
Age
18 years and over
People
120
Run by
RenJi Hospital
See details and how to joinNCT05894863
No phaseNot yet taking people in China
Atherectomy Followed With a Drug Coated Balloon in the Treatment of Long Femoropopliteal Lesions
Where
Shanghai
Age
18 years to 85 years
People
100
Run by
RenJi Hospital
See details and how to joinNCT05868564